Abstract
The understanding of the clinical characteristics of the spectrum of optic neuromyelitis disorders (NMOSD) with partial myelitis and typical optic neuritis has extended the diagnosis in atypical cases. We present the case of a 47-year-old woman who debuts with atypical optic neuritis and partial myelitis. Magnetic resonance imaging and orbits with optic nerve enhancement, optical chiasm and right optic tract, cervical and thoracic spine contrasted with partial myelitis at level C4 and T2. I t was treated with boluses of Methylprednisolone and plasmapheresis, with good clinical response. Aquaporina 4 Serum positive antibodies were performed.
References
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-89.
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica Wingerchuk, D.M. et al., 2007. The spectrum of neuromyelitis optica. , 6(September). 2007;6(September).
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aqua-porin-4 water channel. J Exp Med [Internet]. 2005;202(4):473-7. Available from: http://www.jem.org/lookup/doi/10.1084/jem.20050304
Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol [Internet]. 2012;11(6):535-44. Available from: http://dx.doi.org/10.1016/S1474-4422(12)70133-3
Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation [Internet]. 2012;9(1):14. Available from: http://www.jneuroinflammation.com/con-tent/9/1/14
Kim SH, Kim W Li XF, Jung IJ, Kim HJ. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012;78(15):1179-85.
Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012;135(6):1834-49.
Hyun JW, Kim SH, Jeong IH, Lee SH, Kim HJ. Bright spotty lesions on the spinal cord: An additional MRI indicator of neuromyelitis optica spectrum disorder? J Neurol Neurosurg Psychiatry. 2015;86(11):1280-2.
Sepúlveda M, Armangué ?, Sola-Valls N, Arrambide G, Meca-Lallana JE, Oreja-Guevara C, et al. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus. Neurol Neuroimmunol NeuroInflammation. 2016;3(3):1-9.
Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, Jacobson DJ, Majed M, et al. Epidemiology of aquaporin-4 autoim-munity and neuromyelitis optica spectrum. Ann Neurol. 2016;79(5):775-83.
Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2003;2(9):555-62.
Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016;15(9):967-81.
Confavreux C, Vukusic S. Natural history of multiple sclerosis: A unifying concept. Brain. 2006;129(3):606-16.
Bourre B, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S, et al. Longterm follow-up of acute partial transverse myelitis. Arch Neurol. 2012;69(3):357-62.
Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81-7.
Huh S-Y, Kim S-H, Hyun J-W, Jeong IH, Park MS, Lee S-H, et al. Short segment myelitis as a first manifestation of neu-romyelitis optica spectrum disorders. Mult Scler J [Internet]. 2017 Mar 9;23(3):413-9. Available from: http://132.248.9.34/hevila/Medunab/2010/vol13/no2/6.pdf
T.F. Scott; E.M. Frohman; J. De Seze; G.S. Gronseth; B. G. Weinshenker. Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis. Neurology. 2011;77(December, 7):2128-34.
Hyun JW, Jeong IH, Joung A, Kim SH, Kim HJ. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder. Neurology. 2016;86(19):1772-9.
De Carvalho Jennings Pereira WL, Reiche EMV, Kallaur AP, Kaimen-Maciel DR. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. J Neurol Sci [Internet]. 2015;355(1-2):7-17. Available from: http://dx.doi.org/10.1016/j.jns.2015.05.034
Etemadifar M, Nasr Z, Khalili B, Taherioun M, Vosoughi R. Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis. Mult Scler Int [Internet]. 2015;2015:1-8. Available from: http://www.hindawi.com/journals/msi/2015/174720/
Asgari N, Lillevang ST, Skejoe HPB, Falah M, Stenager E, Kyvik KO. A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011;76(18):1589-95.
Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, et al. Demographic and clinical features of neuromyelitis optica: A review. Mult Scler J. 2015;21(7):845-53.
Cabre P, Gonzalez-Quevedo A, Lannuzel A, Bonnan M, Merle H, Olindo S, et al. Epidémiologie Descriptive De La Neuromyélite Optique Dans Le Bassin Caraïbéen. Rev Neurol (Paris). 2009;165(8-9):676-83.
Rivera VM, Cabrera JA, Mirsattari S, Power C. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology [Internet]. 2001 Sep 11;57(5):937-8. Available from: http://www.neurology.org/cgi/doi/10.1212/WNL.57.5.937
Rivera JF, Kurtzke JF, Booth VJA, Corona T. Characteristics of Devic's disease (neuromyelitis optica) in Mexico. J Neurol [Internet]. 2008 May 19;255(5):710-5. Available from: http://link.springer.com/10.1007/s00415-008-0781-2
Sellner J, Hemmer B, Mühlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun. 2010;34(4):371-9.
Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617-29.
Popescu B, Lennon V, Parisi J. Neuromyelitis optica unique area postrema lesions. Neurology [Internet]. 2011;(76):1229-37. Available from: http://www.neurology.org/content/76/14/1229.short
Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol. 2004;251(1):47-52.
Verkman AS. Aquaporins in Clinical Medicine. Annu Rev Med [Internet]. 2012;63(1):303-16. Available from: http://www.annualreviews.org/doi/10.1146/annurev-med-043010-193843
Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, et al. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2013;84(8):922-30.
Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol [Internet]. 2011;138(3):247-54. Available from: http://dx.doi.org/10.1016/j.clim.2010.11.013
Akman-Demir G, Tüzün E, Waters P, Içõz S, Kürtüncü M, Jarius S, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol. 2011;258(3):464-70.
Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y, et al. HLA-DPB1*0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in Southern Han Chinese. J Neuroimmunol [Internet]. 2011;233(1-2):181-4. Available from: http://dx.doi.org/10.1016/j.jneuroim.2010.11.004
Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566-9.
Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 2001;56(4):507-14.
Uzawa A, Mori M, Kuwabara S. Neuromyelitis optica: Concept, immunology and treatment. J Clin Neurosci [Internet]. 2014;21(1):12-21. Available from: http://dx.doi.org/10.1016/j.jocn.2012.12.022
Lucchinetti CF, Guo Y, Popescu BFG, Fujihara K, Itoyama Y, Misu ?. The pathology of an autoimmune astrocytopathy: Lessons learned from neuromyelitis optica. Brain Pathol. 2014;24(1):83-97.
Jarius S, Wildemann B, Paul F. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2):149-64.
Dumrikarnlert C, Siritho S, Chulapimphan P, Ngamsombat C, Satukijchai C, Prayoonwiwat N. The characteristics of spinal imaging in different types of demyelinating diseases. J Neurol Sci [Internet]. 2017;372(January 2015):138-43. Available from: http://dx.doi.org/10.1016/j.jns.2016.11.035
Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures. J Neurol Sci [Internet]. 2011;306(1-2):82-90. Available from: http://dx.doi.org/10.1016/j.jns.2011.03.038
Seewann A, Enzinger C, Filippi M, Barkhof F, Rovira A, Gass A, et al. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings. J Neurol. 2008;255(1):1-10.
Eckstein C, Saidha S, Levy M. A differential diagnosis of central nervous system demyelination: Beyond multiple sclerosis. J Neurol. 2012;259(5):801-16.
Barreras P, Fitzgerald KC, Mealy MA, Jimenez JA, Becker D, Newsome SD, et al. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy. Neurology [Internet]. 2017;0:10.1212/WNL.0000000000004765. Available from: http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000004765
Hu H, You X, Ye J. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord [Internet]. 2018;21:78-83. Available from: https://doi.org/10.1016/j.msard.2018.02.022
Carnero Contentti E, Hryb JP, Morales S, Gomez A, Chiganer E, Di Pace JL, et al. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity. J Neurol Sci [Internet]. 2017;373:134-7. Available from: http://dx.doi.org/10.1016/j.jns.2016.12.033
Borisow N, Mori M, Kuwabara S, Scheel M, Paul F. Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis. Front Neurol [Internet]. 2018;9(October):1-15. Available from: https://www.frontiersin.org/article/10.3389/fneur.2018.00888/full
Bouzar M, Daoudi S, Hattab S, Bouzar AA, Deiva K, Wildemann B, et al. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aqua-porin-4: Clinical and paraclinical characteristics in Algerian patients. J Neurol Sci [Internet]. 2017;381:240-4. Available from: http://dx.doi.org/10.1016/j.jns.2017.08.3254
Akaishi ?, Nakashima I, Sato DK, Takahashi ?, Fujihara K. Neuromyelitis Optica Spectrum Disorders. Neuroimaging Clin N Am [Internet]. 2017 May;27(2):251-65. Available from: http://dx.doi.org/10.1016/j.nic.2016.12.010
Zhang J, Liu F, Wang Y, Yang Y, Huang Y, Zhao H, et al. Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases. Mult Scler J [Internet]. 2017 Dec 5;23(14):1950-4. Available from: http://132.248.9.34/hevila/Medunab/2010/vol13/no2/6.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.